Clinical Trials Old

QEI’s clinical trials program supports the care of future patients, by collecting information on the benefits and risks of therapeutic, preventative, or diagnostic products and interventions.

Clinical trials confirm whether new medicines and treatments are safe and effective to introduce as new treatments for a particular disease or condition.

At the Queensland Eye Institute we are committed to supporting initiatives that improve health outcomes for patients with eye disease including improved access to new drugs that may be more effective than those currently available.

Our current clinical trials include:

Thyroid Eye Disease: recruitment open


Ongoing Studies – recruitment closed:

Stargardt Disease

Geographic atrophy (GA) associated with age-related macular degeneration (AMD)

Retinitis pigmentosa (RP) associated with Usher Syndrome